Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ARYDNASDAQ:ETAONASDAQ:PRE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARYDARYA Sciences Acquisition Corp IV$6.64-25.9%$8.77$6.25▼$11.57$50.07MN/A40,002 shs94,400 shsETAOETAO International$2.99$1.70▼$22.00$2K1.92248,920 shs1 shsPREPrenetics Global$9.26+23.3%$6.70$3.09▼$11.99$113.02M0.1720,557 shs380,483 shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARYDARYA Sciences Acquisition Corp IV0.00%0.00%0.00%0.00%-42.26%ETAOETAO International0.00%0.00%0.00%0.00%-99.54%PREPrenetics Global0.00%+15.46%+26.85%+128.08%+55.63%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationARYDARYA Sciences Acquisition Corp IVN/AN/AN/AN/AN/AN/AN/AN/AETAOETAO InternationalN/AN/AN/AN/AN/AN/AN/AN/APREPrenetics Global1.0367 of 5 stars1.53.00.00.02.60.01.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARYDARYA Sciences Acquisition Corp IV 0.00N/AN/AN/AETAOETAO International 0.00N/AN/AN/APREPrenetics Global 3.00Buy$9.00-2.81% DownsideCurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARYDARYA Sciences Acquisition Corp IVN/AN/AN/AN/A($3.49) per shareN/AETAOETAO International$58.89M0.00N/AN/A($16.96) per share0.00PREPrenetics Global$41.52M2.72N/AN/A$14.04 per share0.66Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARYDARYA Sciences Acquisition Corp IV-$2.13MN/A0.00∞N/AN/AN/A-6.48%N/AETAOETAO International-$896.68MN/A0.00N/AN/AN/AN/AN/AN/APREPrenetics Global-$46.30M-$3.99N/AN/AN/A-115.91%-28.07%-22.27%N/ALatest ARYD, ETAO, and PRE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/12/2025Q1 2025PREPrenetics GlobalN/A-$0.80N/A-$0.80N/A$17.31 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARYDARYA Sciences Acquisition Corp IVN/AN/AN/AN/AN/AETAOETAO InternationalN/AN/AN/AN/AN/APREPrenetics Global$2.8030.24%N/AN/A N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARYDARYA Sciences Acquisition Corp IVN/A0.010.01ETAOETAO InternationalN/AN/AN/APREPrenetics GlobalN/A2.071.89Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARYDARYA Sciences Acquisition Corp IV48.08%ETAOETAO International0.22%PREPrenetics Global25.01%Insider OwnershipCompanyInsider OwnershipARYDARYA Sciences Acquisition Corp IV53.45%ETAOETAO International20.80%PREPrenetics Global7.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARYDARYA Sciences Acquisition Corp IV37.54 million3.51 millionNot OptionableETAOETAO International3,6005.12 million4.06 millionNot OptionablePREPrenetics Global112.21 million11.25 millionNot OptionableARYD, ETAO, and PRE HeadlinesRecent News About These CompaniesPrenetics Global (NASDAQ:PRE) Stock, Short Interest ReportJune 19 at 6:30 PM | benzinga.comPrenetics Adopts $20M Bitcoin Treasury StrategyJune 19 at 6:31 AM | thecurrencyanalytics.comPrenetics Global First Quarter 2025 Earnings: Revenues Beat Expectations, EPS In LineJune 19 at 1:31 AM | finance.yahoo.comPrenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to BoardJune 18 at 8:45 AM | globenewswire.comPrenetics Global Limited Divests ACT Genomics, Strengthens Financial Position and Raises FY2025 Revenue OutlookJune 18 at 8:28 AM | quiverquant.comPrenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million TransactionJune 18 at 7:50 AM | globenewswire.comShort Interest in Prenetics Global Limited (NASDAQ:PRE) Increases By 46.2%June 16, 2025 | marketbeat.comPrenetics Global Limited Appoints New Independent Director to Strengthen Bitcoin StrategyJune 16, 2025 | tipranks.comEquities Analysts Set Expectations for PRE FY2026 EarningsJune 16, 2025 | americanbankingnews.comBrokers Set Expectations for PRE FY2026 EarningsJune 16, 2025 | marketbeat.comPrenetics Global reports Q1 2025 financialsJune 14, 2025 | uk.investing.comPrenetics Announces First Quarter 2025 Financial Results, Raises FY2025 Outlook, & Crypto Strategy Announcement SoonJune 14, 2025 | nasdaq.comPrenetics Global (NASDAQ:PRE) Issues Quarterly Earnings ResultsJune 12, 2025 | marketbeat.comPrenetics Global Limited (NASDAQ:PRE) Sees Large Decline in Short InterestJune 2, 2025 | marketbeat.comPrenetics Global Full Year 2024 Earnings: Misses ExpectationsMay 3, 2025 | finance.yahoo.comPrenetics Global Limited (PRENW)March 19, 2025 | ca.finance.yahoo.comPrenetics’ IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements MarketMarch 18, 2025 | markets.businessinsider.comPrenetics' IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements MarketMarch 18, 2025 | globenewswire.comPrenetics to Participate in the 37th Annual ROTH ConferenceMarch 11, 2025 | finance.yahoo.comPrenetics Reports Strong 2024 Results and Optimistic 2025 OutlookMarch 5, 2025 | tipranks.comPrenetics Global Limited Reports 93.5% Revenue Growth in Q4 2024 and Provides 2025 Financial GuidanceMarch 5, 2025 | quiverquant.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeAnalysts Think These Stocks Could More Than Double in ValueBy Nathan Reiff | May 23, 2025View Analysts Think These Stocks Could More Than Double in ValueIntel’s Turnaround May Be the Best Bet No One’s WatchingBy Jeffrey Neal Johnson | May 30, 2025View Intel’s Turnaround May Be the Best Bet No One’s WatchingBullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsBy Thomas Hughes | May 27, 2025View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsRKLB Breakout Fails Near Highs: Should Investors Be Concerned?By Ryan Hasson | June 11, 2025View RKLB Breakout Fails Near Highs: Should Investors Be Concerned?ARYD, ETAO, and PRE Company DescriptionsARYA Sciences Acquisition Corp IV NASDAQ:ARYDArya Sciences Acquisition Corp IV does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses on acquiring North American or European companies in the life sciences and medical technology sectors. The company was incorporated in 2020 and is based in New York, New York.ETAO International NASDAQ:ETAOETAO International Co., Ltd., a digital healthcare company, provides medical care services. It develops healthcare ecosystem that consist online telemedicine, artificial intelligence, big data evaluation, online insurance, pharmacy, biotech, offline hospitals, and specialty clinics services. The company was incorporated in 2020 and is based in New York, New York.Prenetics Global NASDAQ:PRE$9.26 +1.75 (+23.30%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$9.54 +0.28 (+3.02%) As of 07:30 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill Chime’s Smart IPO: Half the Valuation, Double the Strength 3 Tech Stocks With High and Rising Institutional Interest Salesforce Raises Prices: 3 Reasons Its Stock Price Will Follow Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
